Associated Genetic Biomarkers

Overview

Gene Location [1]
7p11.2
Pathway
Receptor tyrosine kinase/growth factor signaling
Variant Type
Amplification
Gene
EGFR

EGFR Amplification is present in 1.86% of AACR GENIE cases, with conventional glioblastoma multiforme, lung adenocarcinoma, glioblastoma, breast invasive ductal carcinoma, and esophageal adenocarcinoma having the greatest prevalence [4].

Top Disease Cases with EGFR Amplification

Significance of EGFR Amplification in Diseases

Malignant Solid Tumor +

Glioblastoma +

Breast Carcinoma +

Non-Small Cell Lung Carcinoma +

Colorectal Carcinoma +

Squamous Cell Lung Carcinoma +

Head And Neck Squamous Cell Carcinoma +

Gastric Carcinoma +

Urothelial Carcinoma +

Hepatocellular Carcinoma +

Non-Hodgkin Lymphoma +

Pancreatic Carcinoma +

Malignant Glioma +

Glioma +

Anaplastic Astrocytoma +

Gastric Adenocarcinoma +

Oropharyngeal Squamous Cell Carcinoma +

Cancer +

Melanoma +

Adenocarcinoma Of The Gastroesophageal Junction +

Chordoma +

Gliosarcoma +

Ovarian Carcinoma +

Renal Cell Carcinoma +

Laryngeal Squamous Cell Carcinoma +

Malignant Laryngeal Neoplasm +

Oral Cavity Squamous Cell Carcinoma +

Esophageal Carcinoma +

Oropharyngeal Carcinoma +

Malignant Hepatobiliary Neoplasm +

Hepatobiliary Neoplasm +

Cholangiocarcinoma +

Prostate Carcinoma +

Aggressive Systemic Mastocytosis +

Anal Canal Squamous Cell Carcinoma +

Anaplastic Oligoastrocytoma +

Anaplastic Oligodendroglioma +

B-Cell Non-Hodgkin Lymphoma +

Chondrosarcoma +

Classical Hodgkin Lymphoma +

Desmoid-Type Fibromatosis +

Diffuse Astrocytoma +

Endometrial Carcinoma +

Ewing Sarcoma +

Gastrointestinal Stromal Tumor +

Glioblastoma, IDH-Wildtype +

Hematologic And Lymphocytic Disorder +

Hematopoietic And Lymphoid Malignancy +

Hematopoietic And Lymphoid System Neoplasm +

Histiocytic And Dendritic Cell Neoplasm +

Hypopharyngeal Squamous Cell Carcinoma +

Lip And Oral Cavity Carcinoma +

Liposarcoma +

Low Grade Glioma +

Malignant Salivary Gland Neoplasm +

Malignant Supratentorial Neoplasm +

Mast Cell Leukemia +

Medulloblastoma +

Meningioma +

Multiple Myeloma +

Myelodysplastic Syndromes +

Myeloid Neoplasm +

Nasal Cavity And Paranasal Sinus Carcinoma +

Nasopharyngeal Carcinoma +

Oral Cavity Carcinoma +

Osteosarcoma +

Pecoma +

Pancreatic Adenocarcinoma +

Peritoneal Mesothelioma +

Pituitary Gland Carcinoma +

Small Cell Lung Carcinoma +

Systemic Mastocytosis With An Associated Hematological Neoplasm (SM-AHN) +

Thyroid Gland Carcinoma +

Thyroid Gland Undifferentiated (Anaplastic) Carcinoma +

Undifferentiated Pleomorphic Sarcoma +

Uveal Melanoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.